STOCKSCREENR

AIM

AMEX

AIM ImmunoTech Inc.

$0.52-0.00(-0.64%)Mkt Cap: $1.75M

Key Stats

Market Cap

$1.75M

P/E Ratio

-0.06

EPS

$-8.62

Dividend Yield

0.00%

52-Week Range

$0.48 — $19.74

Volume

216.19K

Avg Volume

4.61M

Beta

1.36

Price Alerts for AIM

Get alerted when AIM hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.06

Forward P/E

—

PEG Ratio

-0.00

P/S (TTM)

20.27

P/B (TTM)

-0.16

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

2.13%

ROA (TTM)

-2.41%

ROIC

—

Gross Margin

-1.56%

Operating Margin

-126.60%

Net Margin

—

Debt/Equity

-0.50

Current Ratio

0.53

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.00%

EPS Growth (5Y)

+0.19%

Sales Growth (3Y)

+0.11%

Sales Growth (5Y)

+0.06%

EPS Est (This Year)

$-4.33

EPS Est (Next Year)

$-1.61

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.32

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

3.28M

Float

2.75M

Free Float %

83.84%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

AMEX

IPO Date

1995-11-02

Employees

21

CEO

Thomas K. Equels

Index Membership

—

Website

https://aimimmuno.com

AIM ImmunoTech Inc. (AIM) is a healthcare company in the biotechnology industry listed on the AMEX. With a market capitalization of $1.75M, a P/E ratio of -0.06, AIM is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AIM against other stocks using dozens of fundamental and technical filters.

Similar Stocks

IBO.V

Universal Ibogaine Inc.

$0.01

-50.00%

$1.56M

MTNB

Matinas BioPharma Holdings, Inc.

$0.70

+7.47%

$3.88M

AZTR

Azitra, Inc.

$0.25

+0.45%

$2.66M

NFX.L

Nuformix plc

$0.17

+0.00%

$3.59M

BRTX

BioRestorative Therapies, Inc.

$0.23

+3.60%

$2.10M

CARM

Carisma Therapeutics, Inc.

$0.04

+0.53%

$1.58M

Frequently Asked Questions

What is AIM ImmunoTech Inc.'s P/E ratio?

AIM ImmunoTech Inc. (AIM) has a trailing twelve-month (TTM) P/E ratio of -0.06. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does AIM ImmunoTech Inc. pay a dividend?

No, AIM ImmunoTech Inc. (AIM) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is AIM ImmunoTech Inc.'s market cap?

AIM ImmunoTech Inc. (AIM) has a market capitalization of $1.75 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.